Navigation Links
PEGINTRON(TM) and REBETOL(R) Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy
Date:11/15/2007

First and Only Peginterferon Therapy Approved for Retreating Both Hepatitis

C Relapsers and Nonresponders

KENILWORTH, N.J., Nov. 15 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that the European Commission on October 30 approved 48-week standard-dose PEGINTRON(TM) (peginterferon alfa- 2b, 1.5 mcg/kg once weekly) and REBETOL(R) (ribavirin, 800 - 1,400 mg daily) combination therapy for retreating adult patients with chronic hepatitis C whose prior treatment with interferon alpha (pegylated or non-pegylated) and ribavirin combination therapy or interferon alpha monotherapy did not result in a sustained response. PEGINTRON and REBETOL is the first and only pegylated interferon combination therapy approved in the European Union (EU) for retreating both hepatitis C relapsers and nonresponders.

The European Commission approval of this expanded indication for PEGINTRON and REBETOL results in Marketing Authorization with unified labeling that is valid in the current EU 27 member states as well as in Iceland and Norway.

"This approval is an option for the large number of hepatitis C patients who failed prior therapy because it gives them a second chance at success," said Nadine Piorkowsky, president of the European Liver Patient Association (ELPA). "These patients want to eradicate the virus and now can determine after 12 weeks of retreatment with PEGINTRON combination therapy whether they are likely to go on to achieve a sustained response with a 48-week course of therapy."

The approval is based on results from an ongoing non-comparative clinical study (EPIC3)(1) in which 1,336 patients with moderate to severe fibrosis or cirrhosis who failed pre
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. $52.5 Million Settlement Against Sepracor Inc. Approved
2. FDA Cracks Down on Unapproved Cough Medicines
3. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
4. Optometry-Backed Vision Care for Kids Act Approved by U.S. House
5. Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis
6. A fresh look at existing therapies: Researchers explore ways to teach approved drugs new tricks
7. Barrs Generic Version of Estrostep(R) Fe Tablets Approved
8. Eligard(R) six-month formulation successfully completes European approval procedure
9. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
10. Medical Services International Inc. Completes Testing for European Union (EU) Application
11. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... July 27, 2015 , ... According to an article published by the ... has increased in Tennessee stemming from intravenous drug use. Intravenous drug use causes more ... for contracting communicable diseases including Hepatitis B and C and HIV. Drug treatment facilities ...
(Date:7/27/2015)... , ... July 27, 2015 , ... ... , providing a new way to understand and share your geospatial experience. These ... creatively designed maps to solve distinct business problems. , “Our world is more ...
(Date:7/27/2015)... ... July 27, 2015 , ... Dentist in Los Angeles , Dr. Poneh Ghasri, is ... of new beginnings for many people. Teeth whitening can help brighten up a person’s look, ... whitening is the safest and most effective way to get a whiter smile. Dr. Ghasri, ...
(Date:7/27/2015)... ... 2015 , ... Sher Fertility Institute, a national network of fertility ... physician to their clinical team in Las Vegas. , Dr. Mark Severino ... successful Reproductive Endocrinology teams in the region. , Combined Drs. Sher and Severino have ...
(Date:7/27/2015)... ... July 27, 2015 , ... The Advocator Group, LLC, a ... Jon Cogswell as the vice president of client services. Mr. Cogswell has over ... significant role in the growth and transformation of several businesses, including Bob’s Discount ...
Breaking Medicine News(10 mins):Health News:Tennessee Sees an Increase in Hepatitis C Infections from Intravenous Heroin Use 2Health News:Tennessee Sees an Increase in Hepatitis C Infections from Intravenous Heroin Use 3Health News:Hexagon Geospatial Visualizes Stories with the Hexagon Smart M.App® 2Health News:Hexagon Geospatial Visualizes Stories with the Hexagon Smart M.App® 3Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Is Now Offering a Teeth Whitening Special Just in Time for Summer 2Health News:Dr. Mark Severino Joins Dr. Geoffrey Sher at Sher Fertility Las Vegas- Sher Fertility is National Network of Fertility Clinics Known for Exceptional Patient Care 2Health News:Dr. Mark Severino Joins Dr. Geoffrey Sher at Sher Fertility Las Vegas- Sher Fertility is National Network of Fertility Clinics Known for Exceptional Patient Care 3Health News:The Advocator Group, LLC Announces Jonathan Cogswell as Vice President of Client Services 2Health News:The Advocator Group, LLC Announces Jonathan Cogswell as Vice President of Client Services 3
... come up with a novel idea to boost up the sales of ... has announced a handsome reward of Rs. 100,000 for those who prove ... case has been registered in the state. And despite this, the bird ... Rs.100,000 if anyone proves bird flu case in the state," Rajesh Kumar ...
... the steel town were affected by a mysterious viral fever. ... a slum// cluster in Panposh on the outskirts of Rourkela, famous ... to other parts of the town. ,The high fever ... senior district health official. ,Most of the patients have ...
... days and devouring every bit of the Flu news, ... Own Country// , as recent as yesterday, has demonstrated a ... Flu or no flu. The Kerala Chicken Merchants’ Association threw ... hotel in Malappuram, Kerala. The party was open for all, ...
... Health officials have now urged cat owners to keep pets indoors. ... Ruegen. Initially it is in this region that more than 100 ... head of Germany's Friedrich Loeffler Institute said that the cat could ... disease was also detected among the wild cats in Asia. But ...
... After the cooling down of the bird flu scare, the ... diet of the non-veggies and has decided to bring back ... withdrawn the order prohibiting the serving of chickens and eggs ... catering units," the Railway ministry said in a statement. "It ...
... goods including small cars, anti-AIDS drugs, anti-cancer drugs would ... is one of the highlights of the annual budget ... ,The beneficiaries of this reduction will be the 800, ... the Tata Indica. The prices of 10 anti-AIDS drugs ...
Cached Medicine News:Health News:Bird Flu attacks the feline community 2
(Date:7/27/2015)... , July 27, 2015 According ... Hybridization Market Study (2014-2019) by Type (DNA ISH, RNA ... By End User (Hospitals, Pharma & Biotech Companies, Research ... at $554.4 million 2014 and is estimated to reach ... during the forecast period, 2014 to 2019. ...
(Date:7/27/2015)... Research and Markets ( http://www.researchandmarkets.com/research/v4wlnk/key_pharma_news ) ... Pharma News Issue" newsletter to their offering. ... burgeoning oncology pipeline and serves as a statement ... in 2015, with a large-scale potentially transformative acquisition ... Key Pharma News covers all major developments in ...
(Date:7/27/2015)... -- Cardica, Inc. (Nasdaq: CRDC ) today announced that it ... June 30, 2015, on Thursday, August 6, 2015, after the ... 4:30 p.m. Eastern Time to discuss the financial results and ... Conference Call Details To access the live conference call on ... please dial 877-703-6106 from the United States ...
Breaking Medicine Technology:Global In-Situ Hybridization Market to be Worth $681.0 Million by 2019 2Global In-Situ Hybridization Market to be Worth $681.0 Million by 2019 3Key Pharma News Issue - Gilead will make further oncology deals in 2015 2Key Pharma News Issue - Gilead will make further oncology deals in 2015 3Cardica To Announce Fiscal 2015 Fourth Quarter Financial Results On Thursday, August 6, 2015 2
... , WALTHAM, Mass., Dec. 14 According ... technology market intelligence, increased use of safety devices for small-bore ... driver of the enteral feeding device markets in both the ... for Enteral Feeding Devices 2010 report finds that the ...
... Colo., Dec. 14 Manchester Pharmaceuticals, Inc.(TM) announced today ... On October 22, 2009, the US Food and Drug ... suffering from gallstones in whom surgery poses an unacceptable ... Chenodal prescriptions have started to be dispensed to patients ...
Cached Medicine Technology:Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3Manchester Announces Availability of Chenodal(TM) 2
The Nervous System Flash Cards product uses the time tested content and images from BryanEdwards.com and displays the necessary images to demonstrate the nervous system....
... Cochrane Reviews enable all those involved ... date with the very latest evidence in ... which becomes harder each year as the ... this problem by delivering the best single ...
... Cochrane Reviews enable all those involved ... date with the very latest evidence in ... which becomes harder each year as the ... this problem by delivering the best single ...
Pocket Medicine's Cardiology Bundle includes the following 4 applications: Treatment Strategies in Cardiovascular Medicine, Treatment Strategies in Interventional Cardiology, Treatment Strategies in ...
Medicine Products: